

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.20910808 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.49809575 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.49809575 |
| 4 | DNA unwinding involved in DNA replication (GO:0006268) | 5.40204844 |
| 5 | DNA strand elongation involved in DNA replication (GO:0006271) | 5.31036370 |
| 6 | telomere maintenance via semi-conservative replication (GO:0032201) | 5.17075209 |
| 7 | response to peptidoglycan (GO:0032494) | 5.12392312 |
| 8 | DNA strand elongation (GO:0022616) | 5.08696730 |
| 9 | viral transcription (GO:0019083) | 4.82509433 |
| 10 | DNA deamination (GO:0045006) | 4.76413050 |
| 11 | translational termination (GO:0006415) | 4.64053323 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.63549971 |
| 13 | telomere maintenance via recombination (GO:0000722) | 4.48464651 |
| 14 | DNA replication initiation (GO:0006270) | 4.33848322 |
| 15 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.21094816 |
| 16 | mitotic recombination (GO:0006312) | 4.19337890 |
| 17 | translational elongation (GO:0006414) | 4.15674456 |
| 18 | cotranslational protein targeting to membrane (GO:0006613) | 4.10779387 |
| 19 | protein targeting to ER (GO:0045047) | 4.08001410 |
| 20 | positive regulation of B cell differentiation (GO:0045579) | 4.03222768 |
| 21 | maturation of SSU-rRNA (GO:0030490) | 3.95650959 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 3.94033501 |
| 23 | negative regulation of phagocytosis (GO:0050765) | 3.93815723 |
| 24 | response to muramyl dipeptide (GO:0032495) | 3.93510875 |
| 25 | mature B cell differentiation involved in immune response (GO:0002313) | 3.90426507 |
| 26 | Peyers patch development (GO:0048541) | 3.89133039 |
| 27 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.89133039 |
| 28 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.87822952 |
| 29 | telomere maintenance via telomere lengthening (GO:0010833) | 3.85129489 |
| 30 | protein localization to endoplasmic reticulum (GO:0070972) | 3.84780566 |
| 31 | ribosomal small subunit biogenesis (GO:0042274) | 3.83559277 |
| 32 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.79643019 |
| 33 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.75275761 |
| 34 | pinocytosis (GO:0006907) | 3.74282213 |
| 35 | lymphoid progenitor cell differentiation (GO:0002320) | 3.68754661 |
| 36 | regulation of mast cell degranulation (GO:0043304) | 3.67554661 |
| 37 | regulation of leukocyte degranulation (GO:0043300) | 3.62052026 |
| 38 | viral life cycle (GO:0019058) | 3.59319984 |
| 39 | detection of other organism (GO:0098543) | 3.55237560 |
| 40 | cellular protein complex disassembly (GO:0043624) | 3.54926072 |
| 41 | positive thymic T cell selection (GO:0045059) | 3.53410100 |
| 42 | detection of bacterium (GO:0016045) | 3.50244775 |
| 43 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.50056798 |
| 44 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.48145248 |
| 45 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.47765117 |
| 46 | translational initiation (GO:0006413) | 3.47445056 |
| 47 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.46888754 |
| 48 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.46888754 |
| 49 | modulation by symbiont of host immune response (GO:0052553) | 3.46888754 |
| 50 | positive regulation by symbiont of host defense response (GO:0052509) | 3.46888754 |
| 51 | modulation by symbiont of host defense response (GO:0052031) | 3.46888754 |
| 52 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.46888754 |
| 53 | regulation of gamma-delta T cell activation (GO:0046643) | 3.46102850 |
| 54 | positive regulation of granulocyte differentiation (GO:0030854) | 3.43742712 |
| 55 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.38433332 |
| 56 | cellular extravasation (GO:0045123) | 3.37304564 |
| 57 | negative regulation of RNA splicing (GO:0033119) | 3.34934025 |
| 58 | regulation of B cell differentiation (GO:0045577) | 3.34311139 |
| 59 | protein complex disassembly (GO:0043241) | 3.33693996 |
| 60 | negative regulation of granulocyte differentiation (GO:0030853) | 3.29753506 |
| 61 | nucleobase biosynthetic process (GO:0046112) | 3.28971136 |
| 62 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.28750857 |
| 63 | IMP biosynthetic process (GO:0006188) | 3.27397609 |
| 64 | protein localization to kinetochore (GO:0034501) | 3.26461140 |
| 65 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.25842499 |
| 66 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.24690268 |
| 67 | IMP metabolic process (GO:0046040) | 3.23216150 |
| 68 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.22990594 |
| 69 | T cell homeostasis (GO:0043029) | 3.20449475 |
| 70 | translesion synthesis (GO:0019985) | 3.20187900 |
| 71 | DNA replication checkpoint (GO:0000076) | 3.20187826 |
| 72 | negative regulation of interleukin-12 production (GO:0032695) | 3.17853355 |
| 73 | negative regulation of B cell apoptotic process (GO:0002903) | 3.16979783 |
| 74 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.14232947 |
| 75 | mast cell activation (GO:0045576) | 3.13014316 |
| 76 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.12210112 |
| 77 | response to host immune response (GO:0052572) | 3.12210112 |
| 78 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.11173902 |
| 79 | macromolecular complex disassembly (GO:0032984) | 3.11110216 |
| 80 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.10310743 |
| 81 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.07092812 |
| 82 | response to host (GO:0075136) | 3.02829270 |
| 83 | response to host defenses (GO:0052200) | 3.02829270 |
| 84 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.02829270 |
| 85 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.02033510 |
| 86 | regulation of erythrocyte differentiation (GO:0045646) | 3.01095428 |
| 87 | regulation of granulocyte differentiation (GO:0030852) | 2.99466690 |
| 88 | mature B cell differentiation (GO:0002335) | 2.98561709 |
| 89 | mRNA catabolic process (GO:0006402) | 2.96421926 |
| 90 | DNA topological change (GO:0006265) | 2.96315295 |
| 91 | intra-S DNA damage checkpoint (GO:0031573) | 2.91104664 |
| 92 | definitive hemopoiesis (GO:0060216) | 2.91010346 |
| 93 | telomere maintenance (GO:0000723) | 2.90936858 |
| 94 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.90586685 |
| 95 | cellular hyperosmotic response (GO:0071474) | 2.90485762 |
| 96 | RNA catabolic process (GO:0006401) | 2.89844246 |
| 97 | telomere organization (GO:0032200) | 2.87456292 |
| 98 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.86432894 |
| 99 | positive regulation of mast cell degranulation (GO:0043306) | 2.86432894 |
| 100 | ribosomal large subunit biogenesis (GO:0042273) | 2.85351582 |
| 101 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.82409645 |
| 102 | regulation of B cell apoptotic process (GO:0002902) | 2.82401845 |
| 103 | CENP-A containing nucleosome assembly (GO:0034080) | 2.82328844 |
| 104 | angiogenesis involved in wound healing (GO:0060055) | 2.81843813 |
| 105 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.79997691 |
| 106 | regulation of monocyte differentiation (GO:0045655) | 2.79298346 |
| 107 | regulation of regulated secretory pathway (GO:1903305) | 2.77739571 |
| 108 | negative thymic T cell selection (GO:0045060) | 2.77657599 |
| 109 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.76663049 |
| 110 | regulation of mast cell activation (GO:0033003) | 2.75006337 |
| 111 | DNA duplex unwinding (GO:0032508) | 2.74699779 |
| 112 | positive regulation of antigen processing and presentation (GO:0002579) | 2.73828921 |
| 113 | chromatin remodeling at centromere (GO:0031055) | 2.73723473 |
| 114 | purine nucleobase biosynthetic process (GO:0009113) | 2.72005383 |
| 115 | DNA geometric change (GO:0032392) | 2.71813359 |
| 116 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.71806933 |
| 117 | DNA replication-independent nucleosome organization (GO:0034724) | 2.71806933 |
| 118 | protein localization to chromosome, centromeric region (GO:0071459) | 2.70761169 |
| 119 | negative regulation of mRNA processing (GO:0050686) | 2.69724756 |
| 120 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.69111002 |
| 121 | detection of external biotic stimulus (GO:0098581) | 2.68197792 |
| 122 | formation of translation preinitiation complex (GO:0001731) | 2.67681399 |
| 123 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.66692203 |
| 124 | myeloid cell activation involved in immune response (GO:0002275) | 2.66194310 |
| 125 | pseudouridine synthesis (GO:0001522) | 2.65613922 |
| 126 | positive regulation of mast cell activation (GO:0033005) | 2.65338303 |
| 127 | macrophage activation involved in immune response (GO:0002281) | 2.65017987 |
| 128 | immunoglobulin mediated immune response (GO:0016064) | 2.64791756 |
| 129 | defense response to protozoan (GO:0042832) | 2.64723207 |
| 130 | mast cell degranulation (GO:0043303) | 2.64036909 |
| 131 | mast cell activation involved in immune response (GO:0002279) | 2.64036909 |
| 132 | response to interferon-beta (GO:0035456) | 2.63134309 |
| 133 | positive regulation of leukocyte degranulation (GO:0043302) | 2.63114113 |
| 134 | response to protozoan (GO:0001562) | 2.63068490 |
| 135 | actin nucleation (GO:0045010) | 2.61224443 |
| 136 | protein targeting to membrane (GO:0006612) | 2.61214624 |
| 137 | pentose-phosphate shunt (GO:0006098) | 2.61107377 |
| 138 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.60759728 |
| 139 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.59353557 |
| 140 | regulation of protein heterodimerization activity (GO:0043497) | 2.59132847 |
| 141 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.58787222 |
| 142 | ncRNA 3-end processing (GO:0043628) | 2.58248267 |
| 143 | B cell receptor signaling pathway (GO:0050853) | 2.57761423 |
| 144 | base-excision repair (GO:0006284) | 2.56671472 |
| 145 | germinal center formation (GO:0002467) | 2.55441011 |
| 146 | regulation of antigen processing and presentation (GO:0002577) | 2.55109407 |
| 147 | macrophage differentiation (GO:0030225) | 2.54806098 |
| 148 | deoxyribose phosphate catabolic process (GO:0046386) | 2.54464306 |
| 149 | UV protection (GO:0009650) | 2.54271777 |
| 150 | positive T cell selection (GO:0043368) | 2.53979197 |
| 151 | megakaryocyte development (GO:0035855) | 2.53098860 |
| 152 | platelet dense granule organization (GO:0060155) | 2.52249598 |
| 153 | leukocyte aggregation (GO:0070486) | 2.51308553 |
| 154 | translation (GO:0006412) | 2.51216724 |
| 155 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.50433789 |
| 156 | respiratory burst (GO:0045730) | 2.50390891 |
| 157 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.48806587 |
| 158 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.48593309 |
| 159 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.48522330 |
| 160 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.48265857 |
| 161 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.47570559 |
| 162 | termination of RNA polymerase II transcription (GO:0006369) | 2.47367888 |
| 163 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.46472986 |
| 164 | detection of biotic stimulus (GO:0009595) | 2.46337472 |
| 165 | establishment of integrated proviral latency (GO:0075713) | 2.46321553 |
| 166 | mismatch repair (GO:0006298) | 2.46273861 |
| 167 | response to thyroid hormone (GO:0097066) | 2.46099298 |
| 168 | negative T cell selection (GO:0043383) | 2.45979493 |
| 169 | T cell selection (GO:0045058) | 2.45896012 |
| 170 | B cell mediated immunity (GO:0019724) | 2.45888635 |
| 171 | mannose metabolic process (GO:0006013) | 2.45632401 |
| 172 | deoxyribonucleotide catabolic process (GO:0009264) | 2.45305427 |
| 173 | cellular response to interferon-beta (GO:0035458) | 2.44573233 |
| 174 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.43791698 |
| 175 | regulation of superoxide anion generation (GO:0032928) | 2.41479234 |
| 176 | thymic T cell selection (GO:0045061) | 2.39172137 |
| 177 | regulation of necrotic cell death (GO:0010939) | 2.38361750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 9.36758518 |
| 2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.52333525 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.15251568 |
| 4 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.02300774 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.78865048 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 2.76305576 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.75878093 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.71614770 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.60095401 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.60009296 |
| 11 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.57782503 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.51520224 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.41377523 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.39688518 |
| 15 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.37801712 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.37312355 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.22488311 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.19272454 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.14886816 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12692699 |
| 21 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.09108731 |
| 22 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.07350800 |
| 23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06340226 |
| 24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.05359467 |
| 25 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.04024723 |
| 26 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.00354249 |
| 27 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.99232928 |
| 28 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.97133229 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.88025097 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.86205310 |
| 31 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.84617611 |
| 32 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.84149974 |
| 33 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84078982 |
| 34 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.83222617 |
| 35 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.82382776 |
| 36 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.82308849 |
| 37 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.82255929 |
| 38 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.81778305 |
| 39 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.80106879 |
| 40 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.79526728 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.76606263 |
| 42 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.76343446 |
| 43 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.72498832 |
| 44 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.70192392 |
| 45 | MYB_26560356_Chip-Seq_TH2_Human | 1.68643080 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.68491896 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.67294256 |
| 48 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.66972604 |
| 49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.66349736 |
| 50 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62672944 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61808715 |
| 52 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.60556721 |
| 53 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.59682456 |
| 54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.59471132 |
| 55 | MAF_26560356_Chip-Seq_TH1_Human | 1.55445666 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.55200014 |
| 57 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.52813014 |
| 58 | MYB_26560356_Chip-Seq_TH1_Human | 1.50800193 |
| 59 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.49307832 |
| 60 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.49196689 |
| 61 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.48882458 |
| 62 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48101422 |
| 63 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.46115489 |
| 64 | UTX_26944678_Chip-Seq_JUKART_Human | 1.45903234 |
| 65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.45579194 |
| 66 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44958055 |
| 67 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.43094366 |
| 68 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.42542488 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.38557320 |
| 70 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.37969317 |
| 71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.37568339 |
| 72 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.37552925 |
| 73 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.36781005 |
| 74 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34451151 |
| 75 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.34248948 |
| 76 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.31716807 |
| 77 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31349970 |
| 78 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.30422806 |
| 79 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.30237189 |
| 80 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.30065871 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29694860 |
| 82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29025808 |
| 83 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.27675901 |
| 84 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.27450828 |
| 85 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.26418864 |
| 86 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.25337506 |
| 87 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.24051620 |
| 88 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22465353 |
| 89 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.21934109 |
| 90 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21519479 |
| 91 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.20985728 |
| 92 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.20974154 |
| 93 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20825273 |
| 94 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.18499610 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17919986 |
| 96 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.16566393 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16271825 |
| 98 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15631214 |
| 99 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.14406753 |
| 100 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.13002645 |
| 101 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.12657398 |
| 102 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11764106 |
| 103 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.09215771 |
| 104 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.07957578 |
| 105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07843720 |
| 106 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.05246511 |
| 107 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.04973863 |
| 108 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04392808 |
| 109 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04362461 |
| 110 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.04337435 |
| 111 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04137891 |
| 112 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.03743505 |
| 113 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03124081 |
| 114 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02203108 |
| 115 | MAF_26560356_Chip-Seq_TH2_Human | 1.02153528 |
| 116 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01606228 |
| 117 | P68_20966046_ChIP-Seq_HELA_Human | 1.01429681 |
| 118 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.01348595 |
| 119 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.98369404 |
| 120 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98141074 |
| 121 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98014141 |
| 122 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.97436098 |
| 123 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96748620 |
| 124 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96303308 |
| 125 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96155773 |
| 126 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.95917538 |
| 127 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95416119 |
| 128 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.94678145 |
| 129 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93337874 |
| 130 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93016101 |
| 131 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92289935 |
| 132 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91951212 |
| 133 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91327919 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 5.32581371 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.44032145 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.21659282 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.07852910 |
| 5 | MP0008057_abnormal_DNA_replication | 2.98759672 |
| 6 | MP0004808_abnormal_hematopoietic_stem | 2.76618728 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.70667277 |
| 8 | MP0000685_abnormal_immune_system | 2.50162644 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.48463165 |
| 10 | MP0005174_abnormal_tail_pigmentation | 2.45591331 |
| 11 | MP0009785_altered_susceptibility_to | 2.43360927 |
| 12 | MP0000490_abnormal_crypts_of | 2.42733015 |
| 13 | MP0008007_abnormal_cellular_replicative | 2.42520501 |
| 14 | MP0001545_abnormal_hematopoietic_system | 2.42282893 |
| 15 | MP0005397_hematopoietic_system_phenotyp | 2.42282893 |
| 16 | MP0003077_abnormal_cell_cycle | 2.37507809 |
| 17 | MP0002398_abnormal_bone_marrow | 2.36556605 |
| 18 | MP0003111_abnormal_nucleus_morphology | 2.33828454 |
| 19 | MP0004957_abnormal_blastocyst_morpholog | 2.26846334 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.26358408 |
| 21 | MP0005075_abnormal_melanosome_morpholog | 2.20952675 |
| 22 | MP0005025_abnormal_response_to | 2.20722388 |
| 23 | MP0001800_abnormal_humoral_immune | 2.18065323 |
| 24 | MP0002009_preneoplasia | 2.16216708 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.12284485 |
| 26 | MP0005671_abnormal_response_to | 2.11226454 |
| 27 | MP0001819_abnormal_immune_cell | 2.09274127 |
| 28 | MP0008058_abnormal_DNA_repair | 2.05928036 |
| 29 | MP0002452_abnormal_antigen_presenting | 2.04111641 |
| 30 | MP0000465_gastrointestinal_hemorrhage | 2.02067085 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.99341661 |
| 32 | MP0003436_decreased_susceptibility_to | 1.99022228 |
| 33 | MP0002723_abnormal_immune_serum | 1.98182657 |
| 34 | MP0000716_abnormal_immune_system | 1.97489145 |
| 35 | MP0009278_abnormal_bone_marrow | 1.96202124 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.95303848 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.93513236 |
| 38 | MP0005000_abnormal_immune_tolerance | 1.92052171 |
| 39 | MP0002722_abnormal_immune_system | 1.91536834 |
| 40 | MP0002419_abnormal_innate_immunity | 1.90253073 |
| 41 | MP0002006_tumorigenesis | 1.87479445 |
| 42 | MP0001853_heart_inflammation | 1.84126624 |
| 43 | MP0002429_abnormal_blood_cell | 1.83794278 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.82742325 |
| 45 | MP0005451_abnormal_body_composition | 1.81950378 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.79420133 |
| 47 | MP0010352_gastrointestinal_tract_polyps | 1.73723558 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.70898757 |
| 49 | MP0003866_abnormal_defecation | 1.70241407 |
| 50 | MP0002019_abnormal_tumor_incidence | 1.68040917 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.63252770 |
| 52 | MP0001790_abnormal_immune_system | 1.60851205 |
| 53 | MP0005387_immune_system_phenotype | 1.60851205 |
| 54 | MP0008260_abnormal_autophagy | 1.57852004 |
| 55 | MP0003303_peritoneal_inflammation | 1.57782344 |
| 56 | MP0001873_stomach_inflammation | 1.55110463 |
| 57 | MP0002405_respiratory_system_inflammati | 1.53631418 |
| 58 | MP0002095_abnormal_skin_pigmentation | 1.51643249 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.47071917 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.44690315 |
| 61 | MP0005076_abnormal_cell_differentiation | 1.38521056 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.37953387 |
| 63 | MP0000858_altered_metastatic_potential | 1.33781501 |
| 64 | MP0003724_increased_susceptibility_to | 1.32706222 |
| 65 | MP0000350_abnormal_cell_proliferation | 1.29535705 |
| 66 | MP0010307_abnormal_tumor_latency | 1.27438552 |
| 67 | MP0001845_abnormal_inflammatory_respons | 1.26320876 |
| 68 | MP0006054_spinal_hemorrhage | 1.23900247 |
| 69 | MP0000313_abnormal_cell_death | 1.16970215 |
| 70 | MP0001851_eye_inflammation | 1.16887202 |
| 71 | MP0003075_altered_response_to | 1.09478731 |
| 72 | MP0008932_abnormal_embryonic_tissue | 1.06428819 |
| 73 | MP0002132_abnormal_respiratory_system | 1.06218361 |
| 74 | MP0008469_abnormal_protein_level | 1.01496484 |
| 75 | MP0009379_abnormal_foot_pigmentation | 1.00958720 |
| 76 | MP0004264_abnormal_extraembryonic_tissu | 1.00101936 |
| 77 | MP0009840_abnormal_foam_cell | 0.96834533 |
| 78 | MP0000015_abnormal_ear_pigmentation | 0.96579864 |
| 79 | MP0001986_abnormal_taste_sensitivity | 0.93411703 |
| 80 | MP0006082_CNS_inflammation | 0.93143823 |
| 81 | MP0002998_abnormal_bone_remodeling | 0.92617640 |
| 82 | MP0005666_abnormal_adipose_tissue | 0.91970685 |
| 83 | MP0009764_decreased_sensitivity_to | 0.88689155 |
| 84 | MP0000681_abnormal_thyroid_gland | 0.88440140 |
| 85 | MP0001730_embryonic_growth_arrest | 0.88426069 |
| 86 | MP0004947_skin_inflammation | 0.87481724 |
| 87 | MP0003183_abnormal_peptide_metabolism | 0.86088092 |
| 88 | MP0003786_premature_aging | 0.85848425 |
| 89 | MP0003943_abnormal_hepatobiliary_system | 0.85760550 |
| 90 | MP0000604_amyloidosis | 0.81228013 |
| 91 | MP0000477_abnormal_intestine_morphology | 0.77935269 |
| 92 | MP0003567_abnormal_fetal_cardiomyocyte | 0.77655083 |
| 93 | MP0003172_abnormal_lysosome_physiology | 0.77076452 |
| 94 | MP0000371_diluted_coat_color | 0.76735077 |
| 95 | MP0002080_prenatal_lethality | 0.76369091 |
| 96 | MP0008877_abnormal_DNA_methylation | 0.76322992 |
| 97 | MP0004782_abnormal_surfactant_physiolog | 0.74858027 |
| 98 | MP0005409_darkened_coat_color | 0.73920808 |
| 99 | MP0002075_abnormal_coat/hair_pigmentati | 0.73553404 |
| 100 | MP0009931_abnormal_skin_appearance | 0.72984295 |
| 101 | MP0005621_abnormal_cell_physiology | 0.72759319 |
| 102 | MP0001663_abnormal_digestive_system | 0.72199566 |
| 103 | MP0003448_altered_tumor_morphology | 0.71310453 |
| 104 | MP0005310_abnormal_salivary_gland | 0.70849426 |
| 105 | MP0003453_abnormal_keratinocyte_physiol | 0.68191837 |
| 106 | MP0008873_increased_physiological_sensi | 0.63054900 |
| 107 | MP0005501_abnormal_skin_physiology | 0.62873109 |
| 108 | MP0002796_impaired_skin_barrier | 0.62552261 |
| 109 | MP0005166_decreased_susceptibility_to | 0.62228515 |
| 110 | MP0001533_abnormal_skeleton_physiology | 0.61511742 |
| 111 | MP0000343_altered_response_to | 0.61361877 |
| 112 | MP0006036_abnormal_mitochondrial_physio | 0.59829937 |
| 113 | MP0001697_abnormal_embryo_size | 0.59002997 |
| 114 | MP0002933_joint_inflammation | 0.58548980 |
| 115 | MP0009763_increased_sensitivity_to | 0.57494355 |
| 116 | MP0005220_abnormal_exocrine_pancreas | 0.56847890 |
| 117 | MP0002877_abnormal_melanocyte_morpholog | 0.55717634 |
| 118 | MP0003828_pulmonary_edema | 0.55157057 |
| 119 | MP0006292_abnormal_olfactory_placode | 0.54643779 |
| 120 | MP0003191_abnormal_cellular_cholesterol | 0.53902564 |
| 121 | MP0000598_abnormal_liver_morphology | 0.52693390 |
| 122 | MP0002970_abnormal_white_adipose | 0.52592650 |
| 123 | MP0003984_embryonic_growth_retardation | 0.52229659 |
| 124 | MP0003186_abnormal_redox_activity | 0.52221010 |
| 125 | MP0003221_abnormal_cardiomyocyte_apopto | 0.52008579 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.50424080 |
| 127 | MP0001672_abnormal_embryogenesis/_devel | 0.50308020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thrombocytosis (HP:0001894) | 5.31307163 |
| 2 | Chronic otitis media (HP:0000389) | 5.07043885 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.94266009 |
| 4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.59661457 |
| 5 | Abnormal number of erythroid precursors (HP:0012131) | 4.59655893 |
| 6 | IgM deficiency (HP:0002850) | 4.58001230 |
| 7 | Reticulocytopenia (HP:0001896) | 4.56453554 |
| 8 | Myositis (HP:0100614) | 4.13975705 |
| 9 | Aplastic anemia (HP:0001915) | 4.08229531 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 3.88387835 |
| 11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.61891834 |
| 12 | Acute lymphatic leukemia (HP:0006721) | 3.61884388 |
| 13 | Abnormality of T cell physiology (HP:0011840) | 3.52214890 |
| 14 | Recurrent bronchitis (HP:0002837) | 3.46764534 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 3.44325968 |
| 16 | Increased IgE level (HP:0003212) | 3.41716961 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.39879701 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.39879701 |
| 19 | Abnormality of glycolipid metabolism (HP:0010969) | 3.39879701 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.38091422 |
| 21 | Recurrent viral infections (HP:0004429) | 3.31945389 |
| 22 | Abnormality of macrophages (HP:0004311) | 3.15168517 |
| 23 | Meningitis (HP:0001287) | 3.13692726 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.11519047 |
| 25 | Acute myeloid leukemia (HP:0004808) | 3.10034350 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 3.07606357 |
| 27 | Cellulitis (HP:0100658) | 3.02419632 |
| 28 | B lymphocytopenia (HP:0010976) | 3.00565441 |
| 29 | Abnormality of B cell number (HP:0010975) | 3.00565441 |
| 30 | Thoracic kyphosis (HP:0002942) | 2.97147976 |
| 31 | Petechiae (HP:0000967) | 2.95901632 |
| 32 | Nasal polyposis (HP:0100582) | 2.94700393 |
| 33 | Autoimmune thrombocytopenia (HP:0001973) | 2.91983795 |
| 34 | Abnormality of T cells (HP:0002843) | 2.87186719 |
| 35 | Pallor (HP:0000980) | 2.80746102 |
| 36 | Colon cancer (HP:0003003) | 2.80020093 |
| 37 | Viral hepatitis (HP:0006562) | 2.76256420 |
| 38 | 11 pairs of ribs (HP:0000878) | 2.73810839 |
| 39 | Poikiloderma (HP:0001029) | 2.66328748 |
| 40 | Dysostosis multiplex (HP:0000943) | 2.65685414 |
| 41 | Hepatosplenomegaly (HP:0001433) | 2.65403233 |
| 42 | Autoimmune hemolytic anemia (HP:0001890) | 2.63775251 |
| 43 | Lymphoma (HP:0002665) | 2.62118491 |
| 44 | Recurrent fungal infections (HP:0002841) | 2.60307697 |
| 45 | Macrocytic anemia (HP:0001972) | 2.60033707 |
| 46 | Mediastinal lymphadenopathy (HP:0100721) | 2.58303757 |
| 47 | Papilledema (HP:0001085) | 2.58282944 |
| 48 | Reduced antithrombin III activity (HP:0001976) | 2.56983094 |
| 49 | Interstitial pulmonary disease (HP:0006530) | 2.55763180 |
| 50 | Abnormality of the nasal mucosa (HP:0000433) | 2.55612335 |
| 51 | Abnormality of the fingertips (HP:0001211) | 2.53005955 |
| 52 | Gastrointestinal inflammation (HP:0004386) | 2.52745691 |
| 53 | Abnormality of the thoracic spine (HP:0100711) | 2.50465898 |
| 54 | Agammaglobulinemia (HP:0004432) | 2.48596229 |
| 55 | Urticaria (HP:0001025) | 2.48214735 |
| 56 | Myelodysplasia (HP:0002863) | 2.47647019 |
| 57 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.44998699 |
| 58 | Oral leukoplakia (HP:0002745) | 2.44562085 |
| 59 | Abnormality of the prostate (HP:0008775) | 2.42140126 |
| 60 | Gingivitis (HP:0000230) | 2.40512256 |
| 61 | Hypertensive crisis (HP:0100735) | 2.39568753 |
| 62 | Thyroiditis (HP:0100646) | 2.39180247 |
| 63 | Inflammation of the large intestine (HP:0002037) | 2.37048408 |
| 64 | Chromsome breakage (HP:0040012) | 2.37021066 |
| 65 | Chronic sinusitis (HP:0011109) | 2.35417111 |
| 66 | Type I transferrin isoform profile (HP:0003642) | 2.32063355 |
| 67 | IgG deficiency (HP:0004315) | 2.30196241 |
| 68 | Prolonged bleeding time (HP:0003010) | 2.30192666 |
| 69 | Chronic obstructive pulmonary disease (HP:0006510) | 2.28791166 |
| 70 | Obstructive lung disease (HP:0006536) | 2.28791166 |
| 71 | Fatigue (HP:0012378) | 2.28473277 |
| 72 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.28463336 |
| 73 | Abnormality of DNA repair (HP:0003254) | 2.25785724 |
| 74 | Vacuolated lymphocytes (HP:0001922) | 2.25001978 |
| 75 | Ragged-red muscle fibers (HP:0003200) | 2.23294502 |
| 76 | Purpura (HP:0000979) | 2.22974826 |
| 77 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.22528713 |
| 78 | Polygenic inheritance (HP:0010982) | 2.21318727 |
| 79 | Increased serum ferritin (HP:0003281) | 2.19877808 |
| 80 | Amaurosis fugax (HP:0100576) | 2.19553945 |
| 81 | Lymphopenia (HP:0001888) | 2.18514146 |
| 82 | Microvesicular hepatic steatosis (HP:0001414) | 2.18191190 |
| 83 | Spontaneous hematomas (HP:0007420) | 2.17883839 |
| 84 | Eczematoid dermatitis (HP:0000976) | 2.17478932 |
| 85 | Loss of speech (HP:0002371) | 2.16998514 |
| 86 | Abnormal platelet function (HP:0011869) | 2.15758680 |
| 87 | Impaired platelet aggregation (HP:0003540) | 2.15758680 |
| 88 | Hypoplasia of the thymus (HP:0000778) | 2.14331191 |
| 89 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.14195844 |
| 90 | Combined immunodeficiency (HP:0005387) | 2.13813038 |
| 91 | Sepsis (HP:0100806) | 2.13675240 |
| 92 | Recurrent skin infections (HP:0001581) | 2.13389391 |
| 93 | Birth length less than 3rd percentile (HP:0003561) | 2.12062523 |
| 94 | Granulocytopenia (HP:0001913) | 2.11545454 |
| 95 | Stomatitis (HP:0010280) | 2.11263059 |
| 96 | Agnosia (HP:0010524) | 2.10328166 |
| 97 | Severe combined immunodeficiency (HP:0004430) | 2.09281793 |
| 98 | Bone marrow hypocellularity (HP:0005528) | 2.05789805 |
| 99 | Pulmonary fibrosis (HP:0002206) | 2.02893995 |
| 100 | Hyperacusis (HP:0010780) | 2.02838361 |
| 101 | Abnormality of chromosome stability (HP:0003220) | 2.02385694 |
| 102 | Pancytopenia (HP:0001876) | 2.01926231 |
| 103 | Cutaneous melanoma (HP:0012056) | 2.01548177 |
| 104 | Orchitis (HP:0100796) | 2.01019903 |
| 105 | Gingival bleeding (HP:0000225) | 2.00788513 |
| 106 | Abnormal protein glycosylation (HP:0012346) | 2.00372008 |
| 107 | Abnormal glycosylation (HP:0012345) | 2.00372008 |
| 108 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.00372008 |
| 109 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.00372008 |
| 110 | Leukocytosis (HP:0001974) | 1.99880816 |
| 111 | Encephalitis (HP:0002383) | 1.98602070 |
| 112 | Colitis (HP:0002583) | 1.97726489 |
| 113 | Clubbing of toes (HP:0100760) | 1.96484420 |
| 114 | Chest pain (HP:0100749) | 1.95855737 |
| 115 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.95759280 |
| 116 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.94932815 |
| 117 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.94736824 |
| 118 | Amyloidosis (HP:0011034) | 1.94652405 |
| 119 | Epistaxis (HP:0000421) | 1.94638388 |
| 120 | Arterial thrombosis (HP:0004420) | 1.94550474 |
| 121 | Abnormality of iron homeostasis (HP:0011031) | 1.93914876 |
| 122 | Multiple enchondromatosis (HP:0005701) | 1.93375602 |
| 123 | Entropion (HP:0000621) | 1.93347198 |
| 124 | Eosinophilia (HP:0001880) | 1.92268629 |
| 125 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.91998380 |
| 126 | Recurrent cutaneous fungal infections (HP:0011370) | 1.91998380 |
| 127 | Severe visual impairment (HP:0001141) | 1.91902452 |
| 128 | Microretrognathia (HP:0000308) | 1.90812067 |
| 129 | Seborrheic dermatitis (HP:0001051) | 1.90751518 |
| 130 | Bronchitis (HP:0012387) | 1.90628857 |
| 131 | Abnormality of the columella (HP:0009929) | 1.90518921 |
| 132 | Osteomyelitis (HP:0002754) | 1.89990596 |
| 133 | Abnormality of the thymus (HP:0000777) | 1.89424514 |
| 134 | Albinism (HP:0001022) | 1.88689718 |
| 135 | Basal cell carcinoma (HP:0002671) | 1.86617606 |
| 136 | Abnormality of the peritoneum (HP:0002585) | 1.86144760 |
| 137 | Spinal cord lesions (HP:0100561) | 1.85631565 |
| 138 | Syringomyelia (HP:0003396) | 1.85631565 |
| 139 | Vasculitis (HP:0002633) | 1.84885181 |
| 140 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.84685177 |
| 141 | Erythema (HP:0010783) | 1.84258459 |
| 142 | Skin rash (HP:0000988) | 1.83638367 |
| 143 | Pustule (HP:0200039) | 1.82827196 |
| 144 | Broad face (HP:0000283) | 1.81763813 |
| 145 | Hypergammaglobulinemia (HP:0010702) | 1.81693821 |
| 146 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.80604972 |
| 147 | Skin ulcer (HP:0200042) | 1.79632578 |
| 148 | Abnormality of the preputium (HP:0100587) | 1.79431616 |
| 149 | Progressive muscle weakness (HP:0003323) | 1.78970383 |
| 150 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.78004258 |
| 151 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.77525716 |
| 152 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.77525716 |
| 153 | IgA deficiency (HP:0002720) | 1.77088243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FLT3 | 3.89478975 |
| 2 | EEF2K | 3.72574069 |
| 3 | KIT | 3.33543741 |
| 4 | MAP4K1 | 2.98546984 |
| 5 | PRPF4B | 2.83932536 |
| 6 | WEE1 | 2.62219313 |
| 7 | CDC7 | 2.59738023 |
| 8 | CDK12 | 2.39703016 |
| 9 | STK16 | 2.31798441 |
| 10 | BTK | 2.31135986 |
| 11 | TEC | 2.29636308 |
| 12 | PIM2 | 2.24815072 |
| 13 | SMG1 | 2.23098969 |
| 14 | CSF1R | 2.17508172 |
| 15 | PKN2 | 2.12567281 |
| 16 | NME2 | 1.93233748 |
| 17 | MAP3K10 | 1.90117955 |
| 18 | MAP3K14 | 1.82582804 |
| 19 | SCYL2 | 1.81982724 |
| 20 | RPS6KB2 | 1.79632378 |
| 21 | IRAK4 | 1.77564668 |
| 22 | BRSK2 | 1.69012137 |
| 23 | MAP2K3 | 1.55165753 |
| 24 | TGFBR1 | 1.52919915 |
| 25 | CLK1 | 1.51009866 |
| 26 | PASK | 1.50579007 |
| 27 | MAP3K13 | 1.45734532 |
| 28 | ACVR1B | 1.40724959 |
| 29 | BUB1 | 1.38646136 |
| 30 | BLK | 1.36591453 |
| 31 | JAK3 | 1.36321230 |
| 32 | SYK | 1.36078338 |
| 33 | NEK2 | 1.34497748 |
| 34 | TBK1 | 1.31768243 |
| 35 | DYRK3 | 1.30519115 |
| 36 | VRK1 | 1.29056583 |
| 37 | ZAP70 | 1.25974624 |
| 38 | ATR | 1.24724615 |
| 39 | MAPKAPK3 | 1.24719380 |
| 40 | MKNK1 | 1.24269631 |
| 41 | LRRK2 | 1.21443002 |
| 42 | TNK2 | 1.19163874 |
| 43 | TYK2 | 1.18674739 |
| 44 | GRK6 | 1.18397947 |
| 45 | TESK2 | 1.14158453 |
| 46 | ICK | 1.13919581 |
| 47 | CDK4 | 1.12851885 |
| 48 | FES | 1.10962874 |
| 49 | EIF2AK3 | 1.10036589 |
| 50 | TLK1 | 1.10023986 |
| 51 | PIM1 | 1.08971572 |
| 52 | CDK7 | 1.07843669 |
| 53 | SRPK1 | 1.06202371 |
| 54 | VRK2 | 1.04672553 |
| 55 | TRIB3 | 1.04591603 |
| 56 | RPS6KA4 | 1.04354741 |
| 57 | TAOK3 | 1.03037532 |
| 58 | TSSK6 | 1.02968957 |
| 59 | TAOK2 | 1.02529328 |
| 60 | EIF2AK1 | 1.00720936 |
| 61 | CDK8 | 0.98500983 |
| 62 | CCNB1 | 0.98299352 |
| 63 | MAP3K1 | 0.97627510 |
| 64 | ITK | 0.94417273 |
| 65 | MATK | 0.94190272 |
| 66 | TNIK | 0.92646184 |
| 67 | STK10 | 0.86009864 |
| 68 | CDK19 | 0.84906300 |
| 69 | LCK | 0.84883908 |
| 70 | LYN | 0.82280667 |
| 71 | NLK | 0.81516410 |
| 72 | MKNK2 | 0.81022553 |
| 73 | BRD4 | 0.80274441 |
| 74 | CSK | 0.80231082 |
| 75 | TRPM7 | 0.76098083 |
| 76 | TXK | 0.73715136 |
| 77 | MAP3K6 | 0.72832479 |
| 78 | BRSK1 | 0.72829483 |
| 79 | JAK2 | 0.72701528 |
| 80 | MAPK4 | 0.72646653 |
| 81 | STK4 | 0.70358463 |
| 82 | PAK4 | 0.69646480 |
| 83 | AURKB | 0.68739108 |
| 84 | MAP3K11 | 0.67366765 |
| 85 | IRAK2 | 0.67092712 |
| 86 | IKBKE | 0.65845844 |
| 87 | MAP3K3 | 0.65718629 |
| 88 | CAMK1D | 0.63387363 |
| 89 | TAOK1 | 0.62942141 |
| 90 | RPS6KA6 | 0.62071164 |
| 91 | MTOR | 0.61841104 |
| 92 | HIPK2 | 0.61636755 |
| 93 | HCK | 0.61633295 |
| 94 | MAPK11 | 0.61363457 |
| 95 | ADRBK2 | 0.60953065 |
| 96 | IKBKB | 0.60936863 |
| 97 | DAPK1 | 0.60901545 |
| 98 | CDK9 | 0.59944656 |
| 99 | MAP3K8 | 0.59194665 |
| 100 | MAPKAPK5 | 0.58791818 |
| 101 | MAP2K2 | 0.58707771 |
| 102 | BMPR2 | 0.58290701 |
| 103 | MAP3K12 | 0.56450925 |
| 104 | PLK1 | 0.56012126 |
| 105 | ERN1 | 0.52471704 |
| 106 | RPS6KL1 | 0.51590397 |
| 107 | RPS6KC1 | 0.51590397 |
| 108 | YES1 | 0.51409281 |
| 109 | KDR | 0.49577116 |
| 110 | TTK | 0.49083271 |
| 111 | MARK2 | 0.48865172 |
| 112 | ILK | 0.48749866 |
| 113 | MAPK12 | 0.48263980 |
| 114 | PDPK1 | 0.46547450 |
| 115 | RAF1 | 0.44679562 |
| 116 | PDK1 | 0.44291728 |
| 117 | RIPK4 | 0.43404904 |
| 118 | CDK6 | 0.43110239 |
| 119 | CHEK2 | 0.42815371 |
| 120 | SIK1 | 0.41903929 |
| 121 | IRAK1 | 0.40574498 |
| 122 | MAPK3 | 0.40315329 |
| 123 | RET | 0.39753230 |
| 124 | RPS6KA2 | 0.38964007 |
| 125 | CHEK1 | 0.38249613 |
| 126 | JAK1 | 0.38150827 |
| 127 | IRAK3 | 0.37320808 |
| 128 | PTK6 | 0.36957067 |
| 129 | CDC42BPA | 0.36659323 |
| 130 | MAP3K5 | 0.36164631 |
| 131 | RPS6KA1 | 0.35934700 |
| 132 | CSNK2A2 | 0.35408421 |
| 133 | CDK2 | 0.33718085 |
| 134 | MAPKAPK2 | 0.33660449 |
| 135 | BCKDK | 0.33072427 |
| 136 | MAP2K6 | 0.32602764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.80190441 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 4.17908615 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.75323112 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 3.31300368 |
| 5 | Homologous recombination_Homo sapiens_hsa03440 | 2.93726526 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.59038708 |
| 7 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.51278203 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.40486719 |
| 9 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.37730781 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.30264963 |
| 11 | Cell cycle_Homo sapiens_hsa04110 | 2.02567300 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.97334851 |
| 13 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.85860485 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.85339260 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.82576670 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.81534718 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.77737617 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.72675857 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 1.72328643 |
| 20 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.72224680 |
| 21 | RNA transport_Homo sapiens_hsa03013 | 1.57143039 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.56493161 |
| 23 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.53670974 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.47719267 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.45016519 |
| 26 | RNA polymerase_Homo sapiens_hsa03020 | 1.43687470 |
| 27 | RNA degradation_Homo sapiens_hsa03018 | 1.39750749 |
| 28 | Lysosome_Homo sapiens_hsa04142 | 1.39251436 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.36699966 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.31345566 |
| 31 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.29433807 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29097274 |
| 33 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.28627145 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.26882563 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.21794437 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.17277910 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.14133760 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.12371295 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.11201931 |
| 40 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.11112543 |
| 41 | Protein export_Homo sapiens_hsa03060 | 1.05906528 |
| 42 | Bladder cancer_Homo sapiens_hsa05219 | 1.02583566 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.00401283 |
| 44 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.99461366 |
| 45 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99275699 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.99103834 |
| 47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.98351436 |
| 48 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94899027 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 0.93722538 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92713833 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.91664741 |
| 52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.91399772 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89692014 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.89649563 |
| 55 | Purine metabolism_Homo sapiens_hsa00230 | 0.89361393 |
| 56 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.89158809 |
| 57 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.88746729 |
| 58 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.87789310 |
| 59 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.87406435 |
| 60 | Pertussis_Homo sapiens_hsa05133 | 0.87376531 |
| 61 | Thyroid cancer_Homo sapiens_hsa05216 | 0.86949622 |
| 62 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85725464 |
| 63 | Influenza A_Homo sapiens_hsa05164 | 0.84806254 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84023621 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83064581 |
| 66 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.81627843 |
| 67 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80558252 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 0.80262847 |
| 69 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75686148 |
| 70 | Apoptosis_Homo sapiens_hsa04210 | 0.75509867 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75200599 |
| 72 | Allograft rejection_Homo sapiens_hsa05330 | 0.75164612 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74234894 |
| 74 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74033265 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70736057 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70462736 |
| 77 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.69068678 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68816692 |
| 79 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.68055870 |
| 80 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.67191630 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60881477 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60122805 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57906700 |
| 84 | Amoebiasis_Homo sapiens_hsa05146 | 0.57499756 |
| 85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.56675393 |
| 86 | Platelet activation_Homo sapiens_hsa04611 | 0.55614919 |
| 87 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55326577 |
| 88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53941077 |
| 89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53902552 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52632405 |
| 91 | Basal transcription factors_Homo sapiens_hsa03022 | 0.52055255 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52006293 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51641768 |
| 94 | Tuberculosis_Homo sapiens_hsa05152 | 0.50981804 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50621499 |
| 96 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.50281507 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50203941 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49660299 |
| 99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47829991 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47400488 |
| 101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46263100 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45485217 |
| 103 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.44899869 |
| 104 | Glioma_Homo sapiens_hsa05214 | 0.44779003 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44505737 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42765060 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42406101 |
| 108 | Viral myocarditis_Homo sapiens_hsa05416 | 0.42202523 |
| 109 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41112132 |
| 110 | Prostate cancer_Homo sapiens_hsa05215 | 0.40842825 |
| 111 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40820117 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40663461 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40613721 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.40214078 |
| 115 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39390668 |
| 116 | Salmonella infection_Homo sapiens_hsa05132 | 0.38561411 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37853688 |
| 118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35863916 |
| 119 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.35803770 |
| 120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.35566238 |
| 121 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35376194 |
| 122 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.35043955 |
| 123 | Malaria_Homo sapiens_hsa05144 | 0.33357303 |
| 124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33273967 |
| 125 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.32759242 |
| 126 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32245272 |
| 127 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30819321 |
| 128 | Hepatitis C_Homo sapiens_hsa05160 | 0.29351351 |
| 129 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.29325731 |

